These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 33807034

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype.
    Nili M, Singer D, Hanna M.
    BMC Pulm Med; 2022 Apr 23; 22(1):153. PubMed ID: 35459138
    [Abstract] [Full Text] [Related]

  • 28. Real-life prevalence of progressive fibrosing interstitial lung diseases.
    Gagliardi M, Berg DV, Heylen CE, Koenig S, Hoton D, Tamirou F, Pieters T, Ghaye B, Froidure A.
    Sci Rep; 2021 Dec 14; 11(1):23988. PubMed ID: 34907290
    [Abstract] [Full Text] [Related]

  • 29. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities.
    George PM, Spagnolo P, Kreuter M, Altinisik G, Bonifazi M, Martinez FJ, Molyneaux PL, Renzoni EA, Richeldi L, Tomassetti S, Valenzuela C, Vancheri C, Varone F, Cottin V, Costabel U, Erice ILD working group.
    Lancet Respir Med; 2020 Sep 14; 8(9):925-934. PubMed ID: 32890499
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A, Veeraraghavan S, Renzoni E.
    Chron Respir Dis; 2011 Sep 14; 8(1):53-82. PubMed ID: 21339375
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease-A Systematic Review.
    Puiu R, Motoc NS, Lucaciu S, Ruta MV, Rajnoveanu RM, Todea DA, Man MA.
    Biomolecules; 2024 Feb 20; 14(3):. PubMed ID: 38540667
    [Abstract] [Full Text] [Related]

  • 35. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
    Faverio P, Piluso M, De Giacomi F, Della Zoppa M, Cassandro R, Harari S, Luppi F, Pesci A.
    Respiration; 2020 Feb 20; 99(10):838-845. PubMed ID: 33264777
    [Abstract] [Full Text] [Related]

  • 36. [Use of antifibrotic drugs in interstitial lung disease].
    Kreutz CP, Gesierich W, Behr J, Kneidinger N.
    Dtsch Med Wochenschr; 2022 Oct 20; 147(21):1383-1390. PubMed ID: 36279864
    [Abstract] [Full Text] [Related]

  • 37. Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.
    Richeldi L, Varone F, Bergna M, de Andrade J, Falk J, Hallowell R, Jouneau S, Kondoh Y, Morrow L, Randerath W, Strek M, Tabaj G.
    Eur Respir Rev; 2018 Dec 31; 27(150):. PubMed ID: 30578333
    [Abstract] [Full Text] [Related]

  • 38. Advances with pharmacotherapy for the treatment of interstitial lung disease.
    Comes A, Sgalla G, Perrotta A, Richeldi L.
    Expert Opin Pharmacother; 2022 Mar 31; 23(4):483-495. PubMed ID: 34907821
    [Abstract] [Full Text] [Related]

  • 39. Pathological Insight into 5-HT2B Receptor Activation in Fibrosing Interstitial Lung Diseases.
    Löfdahl A, Tornling G, Wigén J, Larsson-Callerfelt AK, Wenglén C, Westergren-Thorsson G.
    Int J Mol Sci; 2020 Dec 28; 22(1):. PubMed ID: 33379351
    [Abstract] [Full Text] [Related]

  • 40. Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis.
    Piotrowski WJ, Martusewicz-Boros MM, Białas AJ, Barczyk A, Batko B, Błasińska K, Boros PW, Górska K, Grzanka P, Jassem E, Jastrzębski D, Kaczyńska J, Kowal-Bielecka O, Kucharz E, Kuś J, Kuźnar-Kamińska B, Kwiatkowska B, Langfort R, Lewandowska K, Mackiewicz B, Majewski S, Makowska J, Miłkowska-Dymanowska J, Puścińska E, Siemińska A, Sobiecka M, Soroka-Dąda RA, Szołkowska M, Wiatr E, Ziora D, Śliwiński P.
    Adv Respir Med; 2022 Oct 04; 90(5):425-450. PubMed ID: 36285980
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.